Back

The association between steroid use and recurrent venous thromboembolism: from the COMMAND VTE Registry-2

2 September 2024 (09:00 - 09:50)
Organised by: Logo
Congress Presentation Part of: Venous thromboembolism: international perspectives Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Nishikawa Ryusuke

Hamamatsu Rosai Hospital, Hamamatsu (Japan)

9 More presentations in this session

Presentation thumbnail
Application of DOAC Score for the risk-stratification of major bleeding in patients with venous thromboembolism on direct oral anticoagulants: insight from the COMMAND VTE Registry-2
Doctor Y. Nishimoto (Toyonaka, JP)
Abstract Slides Video
Presentation thumbnail
Types of pulmonary hypertension and prognosis in COVID-19: 18-months analysis of BNP-PL national database.
Doctor A. Mamzer (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
A novel dynamic risk score to predict Clinically Significant Bleeding (CSB) after 3 months of anticoagulation in patients with incident Venous ThromboEmbolism (VTE) and without active cancer.
Doctor A. Cohen (London, GB)
Abstract Slides Video
Presentation thumbnail
Validation of the PESI-Echo score: as a prognostic tool for mortality in acute pulmonary thromboembolism in Mexican population.
Slides Video
Presentation thumbnail
Sex differences in in-hospital management and outcomes of patients with acute pulmonary embolism
Professor C. Becattini (Perugia, IT)
Abstract Slides

Access the full session

Session thumbnail
Venous thromboembolism: international perspectives

The Event

Event poster

ESC Congress 2024

2 September 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Clinical features and long-term outcomes of venous thromboembolism in the warfarin era versus in the direct oral anticoagulant era
thumbnail
Congress Presentation
The influence of concomitant antiplatelet therapy in venous thromboembolism patients treated with anticoagulants in the DOAC era: insight from the COMMAND VTE Registry-2
thumbnail
Congress Presentation
Clinical features and long-term outcomes of cancer-associated venous thromboembolism: transition from the warfarin era to the direct oral anticoagulant era

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources